Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Behringer, K"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Behringer, K, Thielen, I, Mueller, H, Goergen, H, Eibl, A D, Rosenbrock, J, Halbsguth, T, Eichenauer, D A, Fuchs, M, Reiners, K S, Renno, J H, van der Ven, K, Kuehr, M, von Wolff, M., Diehl, V, Engert, A, Borchmann, P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc3ee3bfd9b93b7c4486603f777a8a07
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Borchmann P; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany. Electronic address: peter.borchmann@uk-koeln.de., Ferdinandus J; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany., Schneider G; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany., Moccia A; Swiss Group for Clinical Cancer Research, Bern, Switzerland; Oncology Institute of Southern Switzerland, EOC, Medical Oncology, Bellinzona, Switzerland., Greil R; 3rd Medical Department, Paracelcus Medical University, Salzburg, Austria; Salzburg Cancer Research Institute, Cancer Cluster Salzburg, Salzburg, Austria; Arbeitsgemeinschaft Medikamentöse Tumortherapie, Salzburg, Austria., Hertzberg M; Prince of Wales Hospital Department of Haematology and University NSW, Sydney, NSW, Australia; Australasian Leukaemia & Lymphoma Group, Melbourne, VIC, Australia., Schaub V; University of Tübingen, Tübingen, Germany., Hüttmann A; Department of Haematology, University Hospital, University Duisburg-Essen, Essen, Germany., Keil F; Department of Haematology, Hanusch Krankenhaus, Vienna, Austria., Dierlamm J; University Hospital Hamburg-Eppendorf, Hamburg, Germany., Hänel M; Department III of Internal Medicine, Klinikum Chemnitz, Chemnitz, Germany., Novak U; Swiss Group for Clinical Cancer Research, Bern, Switzerland; Department of Medical Oncology, University Hospital Bern, Bern, Switzerland., Meissner J; Department of Hematology and Oncology, University of Heidelberg, Heidelberg, Germany., Zimmermann A; Department of Hematology and Oncology, Klinikum Leverkusen, Leverkusen, Germany., Mathas S; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Berlin, Germany; Humboldt University of Berlin, Berlin Institute of Health, Berlin, Germany; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, Berlin, Germany; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany., Zijlstra JM; Department of Hematology, Amsterdam UMC, Vrije Universiteit, Cancer Center, Amsterdam, Netherlands., Fosså A; Department of Oncology, Oslo University Hospital, Oslo, Norway; Nordic Lymphoma Group, University Hospital of Ulm, Ulm, Germany., Viardot A; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Hertenstein B; Department of Internal Medicine I, Klinikum Bremen Mitte, Bremen, Germany., Martin S; Department of Haematology and Oncology, Robert Bosch Hospital, Stuttgart, Germany., Giri P; Department of Haematology and Bone Marrow Transplant, Royal-Adelaide-Hospital, Adelaide, SA, Australia., Scholl S; Klinik für Innere Medizin II, Jena University Hospital, Jena, Germany., Topp MS; Department of Internal Medicine II, Hematology and Oncology, University Hospital Wuerzburg, Wuerzburg, Germany., Jung W; Department of Haematology and Oncology, Göttingen, Germany., Vucinic V; Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig, Leipzig, Germany., Beck HJ; Department of Medicine III, Universitätsmedizin Mainz, Mainz, Germany., Kerkhoff A; Department for Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Muenster, Muenster, Germany., Unger B; Hämatologie, Onkologie und Tumorimmunologie, HELIOS Klinikum Berlin-Buch, Berlin, Germany., Rank A; Department of Internal Medicine II, University Hospital Augsburg, Augsburg, Germany., Schroers R; Department of Hematology and Oncology, Universitätsklinikum Knappschaftskrankenhaus Bochum, Ruhr-University Bochum, Germany., Zum Büschenfelde CM; Clinic for Hematology, Oncology, Immunology and Palliative Medicine, Vincentius-Deaconry Clinics gAG, Karslruhe, Germany., de Wit M; Clinic for Hematology, Oncology and Palliative Medicine, Vivantes Klinikum Neukölln, Berlin, Germany., Trautmann-Grill K; Medical Clinic I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany., Kamper P; Nordic Lymphoma Group, University Hospital of Ulm, Ulm, Germany; Department of Hematology, University Hospital of Aarhus, Aarhus, Denmark., Molin D; Nordic Lymphoma Group, University Hospital of Ulm, Ulm, Germany; Department of Immunology, Genetics and Pathology, Cancer Immunotherapy, Uppsala University, Uppsala, Sweden., Kreissl S; Ordensklinikum Linz Elisabethinen, Linz, Austria., Kaul H; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany., von Tresckow B; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany; Department of Haematology, University Hospital, University Duisburg-Essen, Essen, Germany., Borchmann S; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany., Behringer K; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany., Fuchs M; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany., Rosenwald A; Institute for Pathology, University Hospital Würzburg, Würzburg, Germany., Klapper W; Karl Lennert Cancer Center, University Hospital Schleswig-Holstein, Kiel, Germany., Eich HT; Department of Radiotherapy, University Hospital of Muenster, Muenster, Germany., Baues C; Department of Radiation Oncology, University Hospital of Ruhr-Universität Bochum, Marien Hospital Herne, Herne, Germany., Zomas A; Global Medical Lead for Lymphoma & Leukemia at Takeda Oncology, Cambridge, MA, USA., Hallek M; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany., Dietlein M; Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Kobe C; Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Diehl V; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany.
Publikováno v:
Lancet (London, England) [Lancet] 2024 Jul 27; Vol. 404 (10450), pp. 341-352. Date of Electronic Publication: 2024 Jul 03.
Autor:
Behringer K; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Thielen I; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Mueller H; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Goergen H; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Eibl AD; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Rosenbrock J; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Halbsguth T; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Eichenauer DA; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Fuchs M; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Reiners KS; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Renno JH; Institute for Clinical Chemistry, University of Cologne, Cologne, Germany., van der Ven K; Department of Gynecological Endocrinology and Reproductive Medicine, University of Bonn, Bonn, Germany., Kuehr M; Department of Gynecological Endocrinology and Reproductive Medicine, University of Bonn, Bonn, Germany., von Wolff M; Department of Gynecological Endocrinology and Reproductive Medicine, University Women's Hospital, Bern, Switzerland., Diehl V; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Engert A; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Borchmann P; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany. Electronic address: peter.borchmann@uni-koeln.de.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2020 Aug; Vol. 31 (8), pp. 1093. Date of Electronic Publication: 2020 Jun 15.
Autor:
Böll B; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany;, Goergen H; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany;, Behringer K; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany;, Bröckelmann PJ; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany;, Hitz F; Cantonal Hospital of St Gallen, St Gallen, Switzerland, and Swiss Group for Clinical Cancer Research, Bern, Switzerland;, Kerkhoff A; University Hospital Münster, Münster, Germany; and., Greil R; Third Medical Department, Paracelcus Medical University, Salzburg, Austria., von Tresckow B; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany;, Eichenauer DA; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany;, Bürkle C; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany;, Borchmann S; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany;, Fuchs M; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany;, Diehl V; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany;, Engert A; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany;, Borchmann P; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany;
Publikováno v:
Blood [Blood] 2016 May 05; Vol. 127 (18), pp. 2189-92. Date of Electronic Publication: 2016 Feb 01.
Autor:
Behringer K; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital of Cologne, Cologne, Germany., Goergen H; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital of Cologne, Cologne, Germany., Hitz F; Cantonal Hospital of St Gallen, St Gallen, Switzerland and SAKK Swiss Group for Clinical Cancer Research, Bern, Switzerland., Zijlstra JM; VU University Medical Center, Amsterdam, Netherlands., Greil R; Third Medical Department, Paracelcus Medical University, Salzburg, Austria., Markova J; University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic., Sasse S; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital of Cologne, Cologne, Germany., Fuchs M; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital of Cologne, Cologne, Germany., Topp MS; University Hospital Würzburg, Würzburg, Germany., Soekler M; University of Tübingen, Tübingen, Germany., Mathas S; Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany., Meissner J; University of Heidelberg, Heidelberg, Germany., Wilhelm M; Klinikum Nürnberg, Nürnberg, Germany., Koch P; University Hospital Münster, Münster, Germany., Lindemann HW; Katholisches Krankenhaus, Hagen, Germany., Schalk E; Department of Haematology and Oncology, Medical Centre, Otto-von-Guericke University Magdeburg, Magdeburg, Germany., Semrau R; Department of Radiation Oncology, University Hospital of Cologne, Cologne, Germany., Kriz J; University Hospital Münster, Münster, Germany., Vieler T; Medizinische Klinik, Universitätsklinik Schleswig-Holstein, Kiel, Germany., Bentz M; Medizinische Klinik, Städtisches Klinikum Karlsruhe, Germany., Lange E; Medizinische Klinik, Hämatologie/Onkologie, Evangelisches Krankenhaus, Hamm, Germany., Mahlberg R; Medizinische Klinik, Krankenanstalt Mutterhaus d. Borromäerinnen, Trier, Germany., Hassler A; Zentrum für Innere Medizin, Hämatologie/Onkologie, Charité Campus Mitte, Berlin, Germany., Vogelhuber M; Medizinische Klinik, Universitätsklinik Regensburg, Regensburg, Germany., Hahn D; Klinik für Onkologie, Katharinenhospital, Stuttgart, Germany., Mezger J; Medizinische Klinik-Hämatologie, Onkologie, Immunologie, Palliativmedizin, St. Vincentius-Kliniken gAG, Karlsruhe, Germany., Krause SW; Department of Internal Medicine 5, Haematology/Oncology, University of Erlangen, Germany., Skoetz N; Cochrane Haematological Malignancies Group, Department of Internal Medicine 1, University Hospital of Cologne, Cologne, Germany., Böll B; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital of Cologne, Cologne, Germany., von Tresckow B; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital of Cologne, Cologne, Germany., Diehl V; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital of Cologne, Cologne, Germany., Hallek M; Department of Internal Medicine 1, University Hospital of Cologne, Cologne, Germany., Borchmann P; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital of Cologne, Cologne, Germany., Stein H; Berlin Reference Center for Lymphoma and Haematopathology, Berlin, Germany., Eich H; University Hospital Münster, Münster, Germany., Engert A; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital of Cologne, Cologne, Germany. Electronic address: a.engert@uni-koeln.de.
Publikováno v:
Lancet (London, England) [Lancet] 2015 Apr 11; Vol. 385 (9976), pp. 1418-27. Date of Electronic Publication: 2014 Dec 22.
Autor:
Eichenauer DA; First Department of Internal Medicine., Thielen I, Haverkamp H, Franklin J, Behringer K, Halbsguth T, Klimm B, Diehl V, Sasse S, Rothe A, Fuchs M, Böll B, von Tresckow B, Borchmann P, Engert A
Publikováno v:
Blood [Blood] 2014 Mar 13; Vol. 123 (11), pp. 1658-64. Date of Electronic Publication: 2014 Jan 29.
Autor:
Behringer K; First Department of Internal Medicine, University Hospital of Cologne, and Institute for Clinical Chemistry, University of Cologne, Cologne, Germany., Thielen I, Mueller H, Goergen H, Eibl AD, Rosenbrock J, Halbsguth T, Eichenauer DA, Fuchs M, Reiners KS, Renno JH, van der Ven K, Kuehr M, von Wolff M, Diehl V, Engert A, Borchmann P
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2012 Jul; Vol. 23 (7), pp. 1818-25. Date of Electronic Publication: 2012 Jan 06.
Autor:
Behringer K; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany. Electronic address: karolin.behringer@uk-koeln.de., Wildt L; University Hospital for Gynecology and Reproduction Medicine., Mueller H; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany., Mattle V; University Hospital for Gynecology and Reproduction Medicine., Ganitis P; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany., van den Hoonaard B; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany., Ott HW; Institute of Medical and Chemical Laboratory Diagnostics (ZIMCL), University Hospital Innsbruck, Innsbruck, Austria., Hofer S; Institute of Medical and Chemical Laboratory Diagnostics (ZIMCL), University Hospital Innsbruck, Innsbruck, Austria., Pluetschow A; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany., Diehl V; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany., Engert A; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany., Borchmann P; German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2010 Oct; Vol. 21 (10), pp. 2052-2060. Date of Electronic Publication: 2010 Mar 19.